Chemed Corp

As of March 31, 2026, Chemed Corp carries a market capitalization of 5.01B, placing it among publicly traded companies globally. Its enterprise value stands at 5.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Chemed Corp's next confirmed earnings release is scheduled for February 25, 2027.

As of March 31, 2026, Chemed Corp has 13.27M shares outstanding.

As of March 31, 2026, Chemed Corp trades at a trailing price-to-earnings ratio of 20.59. The price-to-sales ratio is 2.11, and the price-to-book ratio stands at 5.91.

As of March 31, 2026, Chemed Corp trades at an EV/EBITDA multiple of 13.29 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.95 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Chemed Corp trades at an EV/FCF ratio of 11.76, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 5.23B versus a market cap of 5.01B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Chemed Corp maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 27.94, indicating elevated leverage, while an interest coverage ratio of 203.71 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Chemed Corp posted a return on equity (ROE) of 25.60, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 19.73 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 15.93, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 21.66, useful for judging operating efficiency across full business cycles. The company generates approximately 161,273.92 in revenue per employee across its workforce of 15,753.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 229.10 indicates how many times Chemed Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Chemed Corp recorded 89.16M in income tax expense. That works out to an effective tax rate of 25.55, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 348.94M, leaving 259.78M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 30, 2026, Chemed Corp's stock has gained approximately 17.67% over the past 52 weeks. The 50-day moving average sits at 514.74, while the 200-day moving average is 462.76.

Over the twelve months ended March 31, 2026, Chemed Corp generated 2.54B in revenue and converted that into 259.78M in net income, yielding earnings per share of 18.29. EBITDA reached 393.76M, while operating income came in at 331.89M.

As of March 31, 2026, Chemed Corp holds 16.86M in cash and equivalents against 236.93M in total debt, resulting in a net debt position of 74.34M. Total book value stands at 847.99M, with working capital of -47.35M providing operational flexibility.

Chemed Corp produced 443.75M in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Chemed Corp posted a gross margin of 32.38, reflecting its pricing power and cost economics. The operating margin of 13.06 and net profit margin of 10.23 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Chemed Corp paid dividends of 2.30 per share. The dividend payout ratio of 12.53 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 8.27, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.32, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Chemed Corp shareholders.

Chemed Corp's most recent stock split took place on May 12, 2005 with a 1:2 split ratio.

As of March 31, 2026, Chemed Corp has an Altman Z-Score of 14.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.